The HPV vaccine hype, its sting, and its link to cancer
Is the HPV vaccine real protection or a business with adverse effects? We examine the scientific evidence and the debate over its safety.
English · Original discussion in Spanish · Published
The HPV vaccine: protection or business?
While health authorities insist that the vaccine against the human bicho (HPV) prevents cervical cancer, an analysis of the studies underpinning that link casts doubt on the strength of the evidence. Far from being settled, the debate pits those who see the vaccine as a necessary tool against those who consider it a pharmaceutical business with serious adverse effects.
What does official science say?
The official narrative holds that HPV is the main cause of cervical cancer and that the vaccine, which covers 4 of the more than 200 existing strains, significantly reduces the risk. Critics, however, point out that the studies linking the bicho to cancer lack proper controls and establish mere correlation, not causation. The modus operandi is compared to that of ELbichito-19, where an epidemic is said to have been inflated to sell solutions.
Adverse effects: Russian roulette?
The HPV vaccine is associated with side effects ranging from mild allergic reactions to Guillain-Barré syndrome, a neurological condition that can cause paralysis. In Spain, an association of those affected documents severe cases. Although the incidence is low, the risk is considered unacceptable for a condition that, in women with a normal immune system, usually resolves on its own. The question that remains: is it worth taking the risk when the very need for the vaccine is debatable?
Health pressure in Spain
Several testimonies denounce that at health centres the vaccine is presented as mandatory, when legally it is only recommended. Patients have even been coerced into having smear tests, under threat of not being prescribed other medications. This fuels distrust of a system that, according to critics, prioritises economic profit over health.
Conclusion: an open debate
The data on the efficacy and safety of the HPV vaccine are not as conclusive as is claimed. While some defend its usefulness in cancer prevention, others call for an independent review of the studies and transparent information about the risks. What seems clear is that informed consent is conspicuously absent.
Related debates in the forum
While health authorities insist that the vaccine against the human bicho (HPV) prevents cervical cancer, an analysis of the studies underpinning that link casts doubt on the strength of the evidence. Far from being settled, the debate pits those who see the vaccine as a necessary tool against those who consider it a pharmaceutical business with serious adverse effects.
What does official science say?
The official narrative holds that HPV is the main cause of cervical cancer and that the vaccine, which covers 4 of the more than 200 existing strains, significantly reduces the risk. Critics, however, point out that the studies linking the bicho to cancer lack proper controls and establish mere correlation, not causation. The modus operandi is compared to that of ELbichito-19, where an epidemic is said to have been inflated to sell solutions.
Adverse effects: Russian roulette?
The HPV vaccine is associated with side effects ranging from mild allergic reactions to Guillain-Barré syndrome, a neurological condition that can cause paralysis. In Spain, an association of those affected documents severe cases. Although the incidence is low, the risk is considered unacceptable for a condition that, in women with a normal immune system, usually resolves on its own. The question that remains: is it worth taking the risk when the very need for the vaccine is debatable?
Health pressure in Spain
Several testimonies denounce that at health centres the vaccine is presented as mandatory, when legally it is only recommended. Patients have even been coerced into having smear tests, under threat of not being prescribed other medications. This fuels distrust of a system that, according to critics, prioritises economic profit over health.
Conclusion: an open debate
The data on the efficacy and safety of the HPV vaccine are not as conclusive as is claimed. While some defend its usefulness in cancer prevention, others call for an independent review of the studies and transparent information about the risks. What seems clear is that informed consent is conspicuously absent.
Related debates in the forum
Also available in: Deutsch
Summary of a discussion on Burbuja.info - Foro de economía, actualidad y política., translated from Spanish and reviewed before publication. Read the full discussion (32 replies).
More summaries
-
Molly Kochan: 200 lovers and divorce before her death
Molly Kochan, diagnosed with terminal cancer, divorced her husband and pursued relationships with 200 men before her death. Her posthumously published story divides...
-
Young Spaniard moves to Germany for love, cheated on by partner
A 19-year-old moved to Germany with his girlfriend to save their relationship, only for her to cheat with a flatmate. Lesson: don't migrate for someone else.
-
Spain's Crisis: Real Estate, Politics, and Market Volatility Explained
An analysis of Spain's real estate, economic, and political bubbles, featuring key data from the Ibex 35 and official bank valuations.
-
The Lady Gaga rumor that started with a single tweet
Lady Gaga's Glastonbury performance revived the rumor about her anatomy: it circulates with no evidence and uses surrogacy as a false clue.
-
AI bias: alone with a Spanish man? It tells you to call 112
When a Spanish man is mentioned, the AI recommends calling 112; without the nationality, it sees no danger. The bias of AI assistants, laid bare.
-
3000 extra cancer deaths in Andalusia over six years are no statistical footnote
Why have cancer deaths in Andalusia, Spain risen by 3000? We break down the debate over health management, environmental causes and the impact on public health.